Evidence map›Paper›PMID 41366501›Full record

ArticleGlobal health research and policy2025

Rethinking global health financing: from philanthropy to public good.

Augustus Osborne

Abstract read
In one paragraph

Article in Global health research and policy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Augustus OsborneInstitute for Development, Western Area, Freetown, Sierra Leone. augustusosborne2@gmail.com.ORCID http://orcid.org/0000-0002-0226-841X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Global health financing has been dominated by philanthropic and donor-driven vertical programs over the past two decades. While this model has achieved major public health gains, it has also entrenched power asymmetries, fostered fragmentation, and undermined the sustainability and sovereignty of health systems in low- and middle-income countries. This perspective critiques the ethical and practical shortcomings of donor-driven approaches, including the marginalization of local ownership and democratic accountability. The COVID-19 pandemic exposed the fragility of relying on voluntary, unpredictable funding and underscored the need for a shift toward treating health as a global public good. The paper argues for a transition to more sustainable models based on domestic resource mobilization, pooled multilateral funding, and participatory governance, and outlines concrete recommendations for reform. Transitioning to a public goods approach requires reforming funding mechanisms to enhance predictability and alignment with national priorities, embedding participatory budgeting and accountability frameworks, and investing in health systems and governance. A new social contract grounded in solidarity, equity, and shared responsibility is essential to secure health for all.

Indexed as

Fund RaisingGlobal HealthHealthcare FinancingCOVID-19Developing CountriesHumansPandemicsPublic HealthSARS-CoV-2Social ResponsibilityEquityGlobal health financingHealth systemsPhilanthropyPublic goods

Identifiers

PMID41366501
PMCPMC12687544

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.